143 related articles for article (PubMed ID: 29882232)
1. Utility of tissue elafin as an immunohistochemical marker for diagnosis of acute skin graft-versus-host disease: a pilot study.
Mahabal GD; George L; Peter D; Bindra M; Thomas M; Srivastava A; Mathews V; George B; Pulimood SA
Clin Exp Dermatol; 2019 Mar; 44(2):161-168. PubMed ID: 29882232
[TBL] [Abstract][Full Text] [Related]
2. Limited utility of plasma elafin as a biomarker for skin graft-versus-host disease following allogeneic stem cell transplantation.
George L; Mahabal G; Mohanan E; Balasubramanian P; Peter D; Pulimood S; Lakshmi K; Jeyaseelan L; Abraham A; Srivastava A; Mathews V; George B
Clin Exp Dermatol; 2021 Dec; 46(8):1482-1487. PubMed ID: 34081805
[TBL] [Abstract][Full Text] [Related]
3. [A preliminary study on clinical diagnostic value of plasma elafin in skin acute graft-versus-host disease].
Luo CW; Weng JY; Wu SJ; Lu ZS; Guo R; Du X
Zhonghua Xue Ye Xue Za Zhi; 2012 Nov; 33(11):922-5. PubMed ID: 23363749
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic role of elafin in skin acute graft versus host disease: a systematic review.
Bhattarai A; Shah S; Yadav R; Dhakal G; Neupane R; Paudel S; Bhandari P; Abu Serhan H; Sah R; Sah S; Barboza JJ
Hematology; 2024 Dec; 29(1):2293497. PubMed ID: 38112182
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Elafin as a Prognostic Biomarker in Acute Graft-versus-Host Disease.
Zewde MG; Morales G; Gandhi I; Özbek U; Aguayo-Hiraldo P; Ayuk F; Baez J; Chanswangphuwana C; Choe H; DeFilipp Z; Etra A; Grupp S; Hexner EO; Hogan W; Javorniczky NR; Kasikis S; Kitko CL; Kowalyk S; Meedt E; Merli P; Nakamura R; Qayed M; Reshef R; Rösler W; Schechter T; Weber D; Wölfl M; Yanik G; Young R; Levine JE; Ferrara JLM; Chen YB
Transplant Cell Ther; 2021 Dec; 27(12):988.e1-988.e7. PubMed ID: 34474163
[TBL] [Abstract][Full Text] [Related]
6. Elafin is a biomarker of graft-versus-host disease of the skin.
Paczesny S; Braun TM; Levine JE; Hogan J; Crawford J; Coffing B; Olsen S; Choi SW; Wang H; Faca V; Pitteri S; Zhang Q; Chin A; Kitko C; Mineishi S; Yanik G; Peres E; Hanauer D; Wang Y; Reddy P; Hanash S; Ferrara JL
Sci Transl Med; 2010 Jan; 2(13):13ra2. PubMed ID: 20371463
[TBL] [Abstract][Full Text] [Related]
7. Epidermal elafin expression is an indicator of poor prognosis in cutaneous graft-versus-host disease.
Brüggen MC; Petzelbauer P; Greinix H; Contassot E; Jankovic D; French L; Socié G; Rabitsch W; Kuzmina Z; Kalhs P; Knobler R; Stingl G; Stary G
J Invest Dermatol; 2015 Apr; 135(4):999-1006. PubMed ID: 25405322
[TBL] [Abstract][Full Text] [Related]
8. Urinary elafin and kidney injury in hematopoietic cell transplant recipients.
Hingorani S; Finn LS; Pao E; Lawler R; Schoch G; McDonald GB; Najafian B; Sandmaier B; Gooley T
Clin J Am Soc Nephrol; 2015 Jan; 10(1):12-20. PubMed ID: 25388519
[TBL] [Abstract][Full Text] [Related]
9. Toxic epidermal necrolysis versus cutaneous Graft-Versus-Host Disease in a hematopoietic stem cell transplant recipient: the role of elafin.
Chen A; Chao K; Rodriguez L; Munday W; Worswick S
Leuk Lymphoma; 2018 Sep; 59(9):2261-2263. PubMed ID: 29322835
[No Abstract] [Full Text] [Related]
10. Composite biomarker panel for prediction of severity and diagnosis of acute GVHD with T-cell-depleted allogeneic stem cell transplants-single centre pilot study.
Min SS; Mehra V; Clay J; Cross GF; Douiri A; Dew T; Basu TN; Potter V; Ceesay MM; Pagliuca A; Sherwood RA; Vincent RP
J Clin Pathol; 2017 Oct; 70(10):886-890. PubMed ID: 28450387
[TBL] [Abstract][Full Text] [Related]
11. Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients.
Lo JW; Leung AY; Huang XR; Lie AK; Metz C; Bucala R; Liang R; Lan HY
Bone Marrow Transplant; 2002 Sep; 30(6):375-80. PubMed ID: 12235522
[TBL] [Abstract][Full Text] [Related]
12. CD123 is a useful immunohistochemical marker to facilitate diagnosis of acute graft-versus-host disease in colon.
Lin J; Chen S; Zhao Z; Cummings OW; Fan R
Hum Pathol; 2013 Oct; 44(10):2075-80. PubMed ID: 23791208
[TBL] [Abstract][Full Text] [Related]
13. Clinical, laboratory, and histopathologic indicators of the development of progressive acute graft-versus-host disease.
Darmstadt GL; Donnenberg AD; Vogelsang GB; Farmer ER; Horn TD
J Invest Dermatol; 1992 Oct; 99(4):397-402. PubMed ID: 1401996
[TBL] [Abstract][Full Text] [Related]
14. The histological diagnosis of cutaneous graft versus host disease: relationship of skin changes to marrow purging and other clinical variables.
Elliott CJ; Sloane JP; Sanderson KV; Vincent M; Shepherd V; Powles R
Histopathology; 1987 Feb; 11(2):145-55. PubMed ID: 3552928
[TBL] [Abstract][Full Text] [Related]
15. Associations between acute GVHD-related biomarkers and endothelial cell activation after allogeneic hematopoietic stem cell transplantation.
Nomura S; Ishii K; Fujita S; Nakaya A; Satake A; Ito T
Transpl Immunol; 2017 Aug; 43-44():27-32. PubMed ID: 28687251
[TBL] [Abstract][Full Text] [Related]
16. Impact of skin biopsy on the management of acute graft-versus-host disease in a pediatric population.
Haimes H; Morley KW; Song H; Okhovat JP; Schmidt B; Huang JT
Pediatr Dermatol; 2019 Jul; 36(4):455-459. PubMed ID: 31016777
[TBL] [Abstract][Full Text] [Related]
17. [A method for modeling skin explants--an in vitro predictive test for graft vs host disease in allogenic hematopoietic cell transplantation].
Hromadníková I; Sedlácek P; Starý J; Vavrinec J; Cermáková-Frantlová M; Stechová K; Houbová B; Vítek A; Sajdová J; Sviland L; Dickinson AM
Cas Lek Cesk; 2001 Feb; 140(3):73-8. PubMed ID: 11284422
[TBL] [Abstract][Full Text] [Related]
18. Histopathologic Features of Cutaneous Acute Graft-Versus-Host Disease in T-Cell-Depleted Peripheral Blood Stem Cell Transplant Recipients.
Fischer A; Jakubowski AA; Lacouture ME; Hollmann TJ; Drucker AM; Maloy M; Prockop S; Querfeld C; Busam KJ; Pulitzer MP
Am J Dermatopathol; 2015 Jul; 37(7):523-9. PubMed ID: 26091510
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical markers for histopathological diagnosis and differentiation of acute cutaneous graft-versus-host disease.
Wegner J; Weidenthaler-Barth B; Engelbert J; Knothe M; Braun C; Helbig D; Sacher C; Kreft A; Wagner EM; Ziemer M; Meyer RG; von Stebut E
Exp Dermatol; 2021 Dec; 30(12):1814-1819. PubMed ID: 34223669
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features of patients with acute graft-versus-host disease of the upper digestive tract.
Nomura K; Iizuka T; Kaji D; Yamamoto H; Kuribayashi Y; Kimura R; Yamada A; Furuhata T; Yamashita S; Kikuchi D; Matsui A; Mitani T; Ogawa O; Hoteya S; Ota Y; Taniguchi S; Kaise M
J Gastroenterol Hepatol; 2014 Nov; 29(11):1867-72. PubMed ID: 24909520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
